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Background: Low vitamin D and adiponectin levels are both associated with obesity and
cardiovascular disease. Previous studies have indicated that vitamin D levels are directly
associated with adiponectin, and that this association varies across body mass index
(BMI) categories; stronger with increasing BMI. Few studies examined this association
in African-Americans (AA), known to have lower levels of vitamin D and adiponectin, and
in whites.
Methods: We assessed whether serum vitamin D is associated with serum adiponectin
in a biracial population-based sample. Cross-sectional analyses were performed on 426
non-diabetic participants (218 whites and 208 AA) from the META-Health Study, a ran-
dom sample from the metro Atlanta. Age-adjusted correlations and multivariable linear
regression were used for analyses. We investigated the effect modification of the BMI
categories of lean, overweight, and obese as defined by standard cut-points (25 and
30 kg/m2).
Results:The mean (SD) age of our study sample was 50.5 (9) years.The mean (SD) levels of
vitamin D were 27.4 (9.8) ng/mL in white women, 25.5 (9.3) ng/mL in white men, 16.9 (7.3)
ng/mL in AA women, and 18.8 (7.3) ng/mL in AA men.The mean (SD) levels of adiponectin
were 17.0 (17.1) µg/mL in white women, 9.9 (11.3) µg/mL in white men, 6.6 (4.8) µg/mL
in AA women, and 9.4 (11.6) µg/mL in AA men. Among lean white women (n=63), there
was a significant direct association between vitamin D and adiponectin (β=0.02, p=0.04)
after adjustment for age, systolic blood pressure, HDL-cholesterol, triglycerides, income,
and season of blood drawing. On the contrary, in lean AA women (n=23), there was a
significant inverse association (β=−0.06, p=0.01).
Conclusion: The association of vitamin D and adiponectin is dependent on race, gender,
and BMI category. Among lean white women, there was a significant direct association,
whereas in lean AA women the association was inverse. No association was present among
obese individuals.
Keywords: vitamin D, adiponectin, obesity, minorities, African-Americans, obesity
INTRODUCTION
Obesity is a global epidemic that is associated with low lev-
els of vitamin D and adiponectin, cardiovascular disease, and
death (1–5). Vitamin D deficiency, as reflected by circulating 25-
hydroxyvitamin D levels <20 ng/mL, is prevalent in as many as
half of middle-aged to elderly adults in developed countries (6).
Adiponectin, the most abundant adipokine, has been suggested to
play an important favorable role in atherosclerosis, endothelial
inflammation, myocardial remodeling, and several of the car-
diometabolic risk factors (7, 8). Low vitamin D and adiponectin
levels are both associated with obesity and cardiovascular disease
(9–11). Besides the favorable effect of both vitamin D and
adiponectin on insulin resistance (12), vitamin D is an essential
steroid metabolite with multiple metabolic effects that includes a
negative regulation of the adipose-tissue renin–angiotensin system
supposed to inhibit adiponectin secretion (13).
Previous studies have indicated that vitamin D levels are directly
associated with adiponectin, and that this association varies across
body mass index (BMI) categories, stronger with increasing BMI
(14–17). Because both low vitamin D and low-adiponectin lev-
els are associated with increased obesity, the association vit-
amin D – adiponectin might represent an explanation for the
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increased cardiovascular risk in obesity. Few studies examined this
association in African-Americans (AA), known to have lower levels
of vitamin D and adiponectin, and in whites (17).
The present study was designed to assess whether serum
vitamin D is associated with serum adiponectin in a biracial
population-based sample of whites and AA. We aimed also to
determine if race and gender modify the association between vit-
amin D and adiponectin. Because a higher adiponectin level may
reduce cardiovascular risk, studies to evaluate the association of
vitamin D and circulating adiponectin, especially in obesity, are
warranted.
MATERIALS AND METHODS
STUDY POPULATION
The META-Health Study (Morehouse and Emory Team up to
eliminate cardiovascular health disparities) is a two-stage study
including a random digit dialing (RDD) interview of self-
identified white and AA residents of metro Atlanta (Cobb, DeKalb,
Fulton, and Gwinnett counties of Georgia), aged 30–66 years, fol-
lowed by a clinic visit with detailed testing in a subsample (18). The
employed sample design was based mainly on the RDD methodol-
ogy where sample telephone numbers were selected in 100-series
telephone banks containing at least one listed household. Nine
calls were placed before deciding a party is “unreachable.” Three
day attempts, three night attempts, and three weekend attempts
were made. The sampling used for this project follows the behav-
ioral risk factor surveillance system (BRFSS) standard for partici-
pating area sample designs. Sample records must be justifiable as
a probability sample of all households with telephones.
A total of 3,391 individuals were interviewed by phone. All
individuals interviewed were asked to come in for a clinic visit to
either the Emory or Morehouse Schools of Medicine. Of these, 219
white and 240 AA men and women were examined at the subse-
quent clinic visit from December 2005 to October 2009 and had
adiponectin and vitamin levels measured, constituting approxi-
mately 14% of those interviewed by phone. Pregnant women and
subjects with acute illnesses were excluded.
We further excluded individuals with missing or incomplete
data in any study variables (n= 33). Therefore, 218 white (71
men and 135 women) and 208 AA (71 men and 137 women)
persons were included in the analysis. Compared to those who
were included in the analysis, there was a lower number of AA
(43 vs. 49%), but similar percentage of women (66 vs. 64%) in
the 3,391 participants that were initially phone-interviewed. This
study was approved by the Emory and Morehouse institutional
review boards and all participants gave informed consent.
COVARIATES
Age, race, and gender were self-identified. Participants were
instructed to fast and to refrain from smoking for 12 h before
the study visit. During the clinic visit, height was measured with
a Portable Shorr Height Measuring Board. All jewelry and hair
dressings were removed and participants were left wearing a dis-
posable lightweight gown and shoes, both provided by the study.
Participants were asked to stand straight with their back against the
measuring board, Frank line horizontal, and heels close together
and legs straight. Height was recorded in centimeters to 0.1 cm.
Body weight was measured with the S 6600 High-Capacity Floor
Scale and weight was recorded in kilograms rounding to the near-
est 0.1 kg. From these data we computed the BMI [BMI=weight
(kg)/height(m)2). BMI was categorized utilizing a standard classi-
fication of normal weight (BMI≤24.9 kg/m2), overweight (25.0≤
BMI <30), and obesity (BMI ≥30 kg/m2). Blood pressure was
determined as the average of three measurements taken after
5 min of silent resting. Lipid variables [high-density lipopro-
tein cholesterol (HDL-C) and triglycerides (TG)], fasting plasma
glucose (FPG), and fasting insulin (FI) were measured using
standard laboratory techniques. Insulin resistance status was esti-
mated with the homeostasis model assessment (HOMA-IR), as
(FPG× FI)/22.5 (19).
VITAMIN D AND ADIPONECTIN MEASUREMENTS
Venous blood samples were withdrawn from each subject at base-
line examination after more than 8 h of fasting as described
elsewhere (18). Serum vitamin D (25-hydroxy-vitamin D) was
measured by a liquid chromatography, tandem mass spectrom-
etry (LC/MS/MS) procedure (20). The extraction was done via
protein precipitation, and the separation via high-performance
liquid chromatography (HPLC). Adiponectin concentration was
measured as total adiponectin by an ELISA system (R&D Sys-
tems, Minneapolis, MN, USA) (21). The inter-assay coefficient
of variation was 8.8%. No biological degradation has been
described using stored specimens, indicating a high validity for
our measurements.
STATISTICAL ANALYSIS
All analyses were stratified by gender to explore heterogeneities
in the independent associations of vitamin D with adiponectin.
Descriptive analyses stratified by gender and race/ethnicity, age-
adjusted correlations, and multivariable linear regression were
used to analyze this association. We investigated the effect mod-
ification of the BMI categories of lean, overweight, and obese as
defined above.
Linear regression models were used to assess the association
of vitamin D with adiponectin with adjustment for age, gen-
der, BMI, systolic blood pressure, HDL-cholesterol, triglycerides,
FPG, insulin resistance estimated with the HOMA-IR, income, and
season of blood drawing.
The dietary intake of vitamin D, available in a subsample of
participants (n= 167, including 68 AA), was used for correlations
with serum vitamin D.
All computations were performed using the SAS software
version 9.2 (SAS® Institute, Inc., Cary, NC, USA).
RESULTS
Among our 426 study participants, the mean (SD) age of the study
sample was 50.5 (9) years (Table 1). The mean (SD) levels of vit-
amin D were 27.4 (9.8) ng/mL in white women, 25.5 (9.3) ng/mL
in white men, 16.9 (7.3) ng/mL in AA (AA) women, and 18.8 (7.3)
ng/mL in AA men (Table 1). Thus, the average vitamin D levels
among AA were in the deficiency category. The mean (SD) levels of
adiponectin were 17.0 (17.1) µg/mL in white women, 9.9 (11.3)
µg/mL in white men, 6.6 (4.8) µg/mL in AA women, and 9.4
(11.6) µg/mL in AA men (Table 1). Therefore, the AA women had
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Table 1 | Sex- and race/ethnicity-specific descriptive characteristics of the study covariates.
Variable Whites African-Americans
Men (N =82) Women (N =136) Men (N =71) Women (N =137)
Mean SD Mean SD Mean SD Mean SD
Vitamin D 25.5 9.3 27.4 9.8 18.8 7.3 16.9 7.3
Adiponectin 9.9 11.3 17.0 17.1 9.4 11.6 6.6 4.8
Age 52.6 8.6 51.9 8.4 49.0 8.5 49.0 9.3
BMI 29.9 6.1 27.4 6.5 30.1 6.9 31.8 7.4
SBP 121.5 14.9 117.6 17.6 123.0 18.5 124.4 19.2
DBP 80.0 10.7 74.9 11.0 79.9 11.8 80.3 12.0
HDL-C 47.9 15.2 65.8 17.8 52.4 13.1 61.9 15.3
TG 168.1 112.6 121.6 66.2 99.5 46.3 93.6 40.1
FPG 98.7 39.5 86.7 8.8 90.5 9.5 89.4 18.6
HOMA-IR 3.37 4.02 2.35 2.83 2.55 2.06 3.03 2.57
SD, standard deviation; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol;TG, triglycerides; SBP, systolic blood pressure; DBP, diastolic blood pressure;
FPG, fasting plasma glucose; HOMA-IR, insulin resistance by homeostasis assessment model HOMA-IR.
Vitamin D was measured in ng/mL, adiponectin in µg/mL, BMI in kg/m2, SBP and DBP in mm of Hg, HDL-C, TG, and FPG in mg/dL.
extremely low-average adiponectin levels, due probably to high-
BMI levels. AA participants had a higher BMI average, but a lower
mean for triglycerides in both genders (Table 1). HDL-cholesterol
was higher in AA men, but lower in AA women (Table 1).
The age-adjusted correlations between vitamin D and
adiponectin were r = 0.38 (p< 0.0001) in white women but not
significant among white men and among AA. Among whites, vita-
min D was statistical significantly correlated with BMI (r =−0.28)
in both genders, with HDL-cholesterol (r = 0.29) in women.
Among AA, vitamin D was significantly correlated in women with
HDL-cholesterol (r = 0.20) and HOMA-IR (r =−0.23). Among
white men participants, adiponectin was age-adjusted correlated
with HDL-cholesterol (r = 0.34) and triglycerides (r =−0.25),
whereas in white women participants adiponectin was corre-
lated with BMI (r =−0.36), HDL-cholesterol (r = 0.48), triglyc-
erides (r =−0.26), and HOMA-IR (r =−0.19). Among AA men
participants, adiponectin was significantly correlated with HDL-
cholesterol (r = 0.32) and HOMA-IR (r =−0.30), whereas in
AA women, adiponectin was correlated with HDL-cholesterol
(r = 0.41), triglycerides (r =−0.25), and HOMA-IR (r =−0.28).
There was a borderline effect modification of the associa-
tion vitamin D – adiponectin by BMI among AA participants
by gender subgroups (p= 0.05), but not among white partic-
ipants. Among lean white women (n= 63), there was a sig-
nificant direct association between vitamin D and adiponectin
(β= 0.02, p= 0.04) after adjustment for age, systolic blood pres-
sure, HDL-cholesterol, triglycerides, income, and season of blood
drawing (Table 2). On the contrary, in lean AA women (n= 23),
there was a significant inverse association (β=−0.06, p= 0.01)
after the same adjustment (Table 2). These estimates remained
unchanged (identical) when additionally adjusting for insulin
resistance (HOMA-IR).
Dietary vitamin D was significantly associated with serum vita-
min D in both white women (r = 0.30) and white men (r = 0.52),
but among AA only in women (r = 0.43).
DISCUSSION
PRINCIPAL FINDINGS
The association of vitamin D and adiponectin is dependent on
race, gender, and BMI category. Among lean white women, there
was a significant direct association, whereas in lean AA women the
association was inverse. No association was present among obese
individuals.
IN THE CONTEXT OF PREVIOUS LITERATURE
Our results are consistent with the observation that AA have lower
plasma levels of vitamin D when compared with their white coun-
terparts. As a recent study indicated, AA in the Southeastern U.S.
are four times as likely to have a sub-optimal vitamin D plasma
concentration (<15 ng/mL) than their white counterparts (22).
A direct association between plasma vitamin D and circulating
adiponectin has been suggested by a series of previous studies (15,
16, 23, 24). Some studies showed that the association was increased
among participants with higher BMI (15, 24). Nevertheless, other
studies failed to identify the same trend, probably due to relatively
lean participants in some of the previous studies (16). Our metro
Atlanta participants had a relatively high BMI and therefore are
well suited to contrast the association vitamin D – adiponectin
among those relatively lean and those obese.
Contrary to some previous studies, we did not find a direct
association between vitamin D and adiponectin among those
participants that are obese. In a recent study with Korean par-
ticipants (25), after adjusting for age, sex, BMI, smoking, and
alcohol intake, serum vitamin D levels showed a significant corre-
lation with adiponectin (p< 0.05) level among overweight and
obese people (BMI >23) who are likely to be at a risk for
cardiovascular disease. In a clinical trial in which 19 vitamin
D-deficient peritoneal dialysis patients were treated with chole-
calciferol, despite a mean 25(OH)D significantly increase, no
change in serum adiponectin after vitamin D replacement was
detected (26). Similarly, serum levels of adiponectin were not
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Table 2 | Associationsa between vitamin D and adiponectin stratified by obesity status.
Lean participantsb Overweight participantsb Obese participantsb
β SE p-value β SE p-value β SE p-value
Whites
Women 0.02 0.01 0.04 0.01 0.02 0.46 0.04 0.02 0.05
Men −0.06 0.06 0.43 −0.02 0.01 0.21 0.003 0.03 0.92
African-Americans
Women −0.06 0.02 0.01 −0.01 0.02 0.50 0.01 0.01 0.20
Men 0.006 0.04 0.89 −0.06 0.05 0.30 0.02 0.03 0.50
aModels were adjusted for age, systolic blood pressure, HDL-cholesterol, triglycerides, income, and season of blood drawing.
bLean participants were those with a BMI <25 kg/m2, overweight those with BMI ≥25 and <30 kg/m2, and obese those with BMI ≥30 kg/m2.
Bold font indicates main findings of investigation.
related with vitamin D and calcium levels in patients with pri-
mary hyperparathyroidism (27). Similarly, to our findings in white
lean participants, controlling for age, sex, race, sexual matura-
tion, season, physical activity, and percent body fat, 25(OH)D
concentrations were significantly correlated with adiponectin
(r = 0.06, p= 0.05) among healthy black and white adolescents
residing at southern U.S. latitudes with a year-round sunny
climate (28).
POTENTIAL MECHANISMS
Vitamin D negatively regulates the expression of renin, and thus,
the activity of the renin–angiotensin system (29, 30). It appears
that adipocytes produce all the components of a local adipose-
tissue renin–angiotensin system whose activity in turn inhibits
adiponectin secretion (31, 32). Since the activity of the adipose-
tissue renin–angiotensin system increases with higher adiposity
(33), it was previously hypothesized that increased adipose-tissue
renin–angiotensin system activity may represent a potential mech-
anism for the relative low-adiponectin levels seen in obesity (23).
The direct association between vitamin D and adiponectin may
be mediated by the negative regulation of the adipose-tissue
renin–angiotensin system by vitamin D metabolites. As our results
showed a direct association vitamin D – adiponectin only among
lean white participants, other mechanisms appear to play a more
important role. Among those is the observation that vitamin D
insufficiency is related to glucose intolerance and type 2 diabetes
(34, 35). It has been shown previously that vitamin D supple-
mentation improves insulin resistance as estimated by HOMA-IR,
the homeostasis model assessment for insulin resistance (12). As
adiponectin is also generally inversely associated with HOMA-
IR, the inverse association between vitamin D and adiponectin
observed among our AA participants that were lean could not
be attributed to such mechanism. Moreover, as mentioned there
was no significant correlation between vitamin D and HOMA-IR,
and the magnitude of the association vitamin D – adiponectin
estimates among our participants did not change after adjust-
ment for HOMA-IR. Therefore, other characteristics of our sample
might play an important role. Among those are the relatively
low levels of vitamin D among our AA participants that can be
explained by their relatively high-BMI average. One of the clini-
cal characteristics associated with vitamin D deficiency is obesity
(36, 37). The association between obesity and vitamin D defi-
ciency is either indirect, as obese individuals tend to have less
outdoor activity and thus less sunlight exposure, or direct, as vit-
amin D is fat soluble and may be sequestered and stored in fat
tissues (38), which decreases the bioavailability of vitamin D in
the circulation.
Therefore, despite a relatively high-average BMI, among our
non-lean women participants and among men participants,
no direct association between vitamin D and adiponectin was
detected. The lower vitamin D due to higher BMI may also
explain the higher adiponectin level. If the adipose tissue is absorb-
ing/metabolizing the vitamin D, then this may lead to adiponectin
synthesis and release. Thus, the inverse relationship in lean AA
women might be a compensatory response to the “normal,” physi-
ological vitamin D, and adiponectin interaction/interrelationship.
Failure to detect this in Caucasians may be a consequence of lower
vitamin D stored within the adipose tissue.
STRENGTHS AND LIMITATIONS
The main strength of our investigation is that this study is among
the first on the topic with inclusion of both white and AA partici-
pants that have a wide range of BMI values. On the other hand, our
study sample is localized to one geographical area, so generalizabil-
ity inherently cannot be inferred. Another important limitation is
the fact that we have a limited sample size. To this should be added
the inherent fact that the first stage of the META-Health Study (as
well as the clinic visit) has a number of epidemiological limitations
(e.g., sampling challenges, non-response bias, social response bias,
other general selection bias, etc.) that are not fully accounted for.
CONCLUSION
While our study adds to the evidence base regarding the rela-
tionship between vitamin D and adiponectin levels in non-white
populations, the results raised a number of unintended questions
about how vitamin D and adiponectin interact in circumstances
when they are not related to weight status. Further research is
clearly needed to evaluate the effects of vitamin D therapy on
circulating adiponectin in relationship with normal weight and
obesity. The design of the present study, unfortunately, lacks the
scope to inform if and how randomized clinical trials (RCT) on vit-
amin D supplementation should be conducted. RCT investigators
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should weigh in on these and other emerging data that describe
the relationships among vitamin D, adiponectin, and individual
characteristics such as race, gender, and BMI category.
The inverse association between vitamin D and adiponectin
among lean AA women might explain the lower levels of
adiponectin among AA due to a possible reduced negative reg-
ulation (e.g., of the adipose-tissue renin–angiotensin system) by
vitamin D metabolites.
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